Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Monoclonal Antibodies
  • 1.4.3 Immunomodulators
  • 1.4.4 Oncolytic Viral Therapies and Cancer Vaccines
  • 1.4.5 Other
• 1.5 Market by Application
  • 1.5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2014-2025)
  • 1.5.2 Lung
  • 1.5.3 Breast
  • 1.5.4 Colorectal
  • 1.5.5 Melanoma
  • 1.5.6 Prostate
  • 1.5.7 Head and Neck
  • 1.5.8 Ovarian
  • 1.5.9 Pancreatic
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size
• 2.2 Cancer Immunotherapy Drug Discovery Outsourcing Growth Trends by Regions
  • 2.2.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions (2014-2025)
  • 2.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by by Players
  • 3.1.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by by Players (2014-2019)
  • 3.1.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio (CR5 and HHI)
• 3.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players Head office and Area Served
• 3.3 Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product/Solution/Service
• 3.4 Date of Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2014-2019)
• 4.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2014-2019)

5 United States

• 5.1 United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2014-2019)
• 5.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in United States
• 5.3 United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
• 5.4 United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

6 Europe

• 6.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2014-2019)
• 6.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Europe
• 6.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
• 6.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

7 China

• 7.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2014-2019)
• 7.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in China
• 7.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
• 7.4 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

8 Japan

• 8.1 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2014-2019)
• 8.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Japan
• 8.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
• 8.4 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2014-2019)
• 9.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Southeast Asia
• 9.3 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
• 9.4 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

10 India

• 10.1 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2014-2019)
• 10.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in India
• 10.3 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
• 10.4 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

11 Central & South America

• 11.1 Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2014-2019)
• 11.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Central & South America
• 11.3 Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
• 11.4 Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

12 International Players Profiles

• 12.1 Aquila BioMedical
  • 12.1.1 Aquila BioMedical Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
  • 12.1.4 Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
  • 12.1.5 Aquila BioMedical Recent Development
• 12.2 BPS Bioscience, Inc.
  • 12.2.1 BPS Bioscience, Inc. Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
  • 12.2.4 BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
  • 12.2.5 BPS Bioscience, Inc. Recent Development
• 12.3 Celentyx Ltd
  • 12.3.1 Celentyx Ltd Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
  • 12.3.4 Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
  • 12.3.5 Celentyx Ltd Recent Development
• 12.4 Crown Bioscience, Inc.
  • 12.4.1 Crown Bioscience, Inc. Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
  • 12.4.4 Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
  • 12.4.5 Crown Bioscience, Inc. Recent Development
• 12.5 DiscoverX Corporation
  • 12.5.1 DiscoverX Corporation Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
  • 12.5.4 DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
  • 12.5.5 DiscoverX Corporation Recent Development
• 12.6 Explicyte
  • 12.6.1 Explicyte Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
  • 12.6.4 Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
  • 12.6.5 Explicyte Recent Development
• 12.7 Genscript Biotech Corporation
  • 12.7.1 Genscript Biotech Corporation Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
  • 12.7.4 Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
  • 12.7.5 Genscript Biotech Corporation Recent Development
• 12.8 HD Biosciences Co.
  • 12.8.1 HD Biosciences Co. Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
  • 12.8.4 HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
  • 12.8.5 HD Biosciences Co. Recent Development
• 12.9 Horizon Discovery Group PLC
  • 12.9.1 Horizon Discovery Group PLC Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
  • 12.9.4 Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
  • 12.9.5 Horizon Discovery Group PLC Recent Development
• 12.10 ImmunXperts SA
  • 12.10.1 ImmunXperts SA Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
  • 12.10.4 ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2014-2019)
  • 12.10.5 ImmunXperts SA Recent Development
• 12.11 Molecular Imaging, Inc.
• 12.12 Promega Corporation,Personalis, Inc.
• 12.13 STC Biologics

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer